STERIS plc (STE) Form 10-K — May 29, 2026
STERIS plc reported fiscal 2026 revenues of $5.94 billion, an 8.7% increase year-over-year, driven by organic growth, pricing, and favorable currency movements. Operating income rose 27.1% to $1.1 billion, benefiting from lower restructuring costs and the absence of the $48.2 million Illinois EO litigation settlement recorded in the prior year. The company generated $982.9 million in free cash flow and maintained a debt-to-total capital ratio of 21.3%. On May 5, 2026, the Board authorized a new $1 billion share repurchase program, replacing the previous program which had $75 million remaining.
Key figures
- Eps
- 8.6
- Guidance
- Expect to manage costs, grow business with internal development, and augment with potential acquisitions.
- Revenue Yoy
- 8.7%
- Backlog
- 490700000
- Free Cash Flow
- 982900000
- Operating Income
- 1101800000
- Dividend Per Share
- 0.63
- Cost Of Shares Repurchased
- 225000000
- Share Repurchase Authorization
- 1000000000
- Organic Growth Constant Currency
- 7.3%
Price after filing
Close on the filing date to close N calendar days later (from $215.40). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.